BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hui B, Shi Y, Ding Z, Zhou J, Gu C, Peng Y, Yang H, Liu W, Shi G, Fan J. Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma. Cancer 2012;118:5560-71. [DOI: 10.1002/cncr.27586] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 5.2] [Reference Citation Analysis]
Number Citing Articles
1 Barakat DJ, Mendonca J, Barberi T, Zhang J, Kachhap SK, Paz-Priel I, Friedman AD. C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion. Cancer Lett 2016;375:152-61. [PMID: 26968249 DOI: 10.1016/j.canlet.2016.03.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
2 Chang T, Liou P, Cheng P, Chang H, Tsai P. Borneol and Luteolin from Chrysanthemum morifolium Regulate Ubiquitin Signal Degradation. J Agric Food Chem 2018;66:8280-90. [DOI: 10.1021/acs.jafc.8b01972] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
3 Baiz D, Dapas B, Farra R, Scaggiante B, Pozzato G, Zanconati F, Fiotti N, Consoloni L, Chiaretti S, Grassi G. Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines. World J Gastroenterol 2014; 20(3): 795-803 [PMID: 24574752 DOI: 10.3748/wjg.v20.i3.795] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
4 Vogl DT, Stadtmauer EA, Tan KS, Heitjan DF, Davis LE, Pontiggia L, Rangwala R, Piao S, Chang YC, Scott EC, Paul TM, Nichols CW, Porter DL, Kaplan J, Mallon G, Bradner JE, Amaravadi RK. Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy 2014;10:1380-90. [PMID: 24991834 DOI: 10.4161/auto.29264] [Cited by in Crossref: 222] [Cited by in F6Publishing: 219] [Article Influence: 31.7] [Reference Citation Analysis]
5 Choi HJ, Park JH, Kim OH, Kim KH, Hong HE, Seo H, Kim SJ. Combining Everolimus and Ku0063794 Promotes Apoptosis of Hepatocellular Carcinoma Cells via Reduced Autophagy Resulting from Diminished Expression of miR-4790-3p. Int J Mol Sci 2021;22:2859. [PMID: 33799789 DOI: 10.3390/ijms22062859] [Reference Citation Analysis]
6 Netea-Maier RT, Klück V, Plantinga TS, Smit JW. Autophagy in thyroid cancer: present knowledge and future perspectives. Front Endocrinol (Lausanne) 2015;6:22. [PMID: 25741318 DOI: 10.3389/fendo.2015.00022] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
7 Mohammad RM, Muqbil I, Lowe L, Yedjou C, Hsu HY, Lin LT, Siegelin MD, Fimognari C, Kumar NB, Dou QP, Yang H, Samadi AK, Russo GL, Spagnuolo C, Ray SK, Chakrabarti M, Morre JD, Coley HM, Honoki K, Fujii H, Georgakilas AG, Amedei A, Niccolai E, Amin A, Ashraf SS, Helferich WG, Yang X, Boosani CS, Guha G, Bhakta D, Ciriolo MR, Aquilano K, Chen S, Mohammed SI, Keith WN, Bilsland A, Halicka D, Nowsheen S, Azmi AS. Broad targeting of resistance to apoptosis in cancer. Semin Cancer Biol 2015;35 Suppl:S78-S103. [PMID: 25936818 DOI: 10.1016/j.semcancer.2015.03.001] [Cited by in Crossref: 266] [Cited by in F6Publishing: 271] [Article Influence: 44.3] [Reference Citation Analysis]
8 Fan J, Shi Y, Peng Y. Autophagy and Liver Diseases. Adv Exp Med Biol 2020;1207:497-528. [PMID: 32671772 DOI: 10.1007/978-981-15-4272-5_37] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Yoo JY, Jaime-Ramirez AC, Bolyard C, Dai H, Nallanagulagari T, Wojton J, Hurwitz BS, Relation T, Lee TJ, Lotze MT, Yu JG, Zhang J, Croce CM, Yu J, Caligiuri MA, Old M, Kaur B. Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy. Clin Cancer Res 2016;22:5265-76. [PMID: 27390350 DOI: 10.1158/1078-0432.CCR-16-1003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 8.6] [Reference Citation Analysis]
10 Ma C, Wen B, Zhang Q, Shao PP, Gu W, Qu K, Shi Y, Wang B. Emodin induces apoptosis and autophagy of fibroblasts obtained from patient with ankylosing spondylitis. Drug Des Devel Ther 2019;13:601-9. [PMID: 30809091 DOI: 10.2147/DDDT.S182087] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
11 Xie T, Li SJ, Guo MR, Wu Y, Wang HY, Zhang K, Zhang X, Ouyang L, Liu J. Untangling knots between autophagic targets and candidate drugs, in cancer therapy. Cell Prolif 2015;48:119-39. [PMID: 25650136 DOI: 10.1111/cpr.12167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
12 Li Y, Luo Y, Luo T, Lu B, Wang C, Zhang Y, Piao M, Feng C, Ge P. Trehalose Inhibits Protein Aggregation Caused by Transient Ischemic Insults Through Preservation of Proteasome Activity, Not via Induction of Autophagy. Mol Neurobiol 2017;54:6857-69. [PMID: 27771898 DOI: 10.1007/s12035-016-0196-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
13 Augello G, Modica M, Azzolina A, Puleio R, Cassata G, Emma MR, Di Sano C, Cusimano A, Montalto G, Cervello M. Preclinical evaluation of antitumor activity of the proteasome inhibitor MLN2238 (ixazomib) in hepatocellular carcinoma cells. Cell Death Dis 2018;9:28. [PMID: 29348495 DOI: 10.1038/s41419-017-0195-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
14 Kim Y, Lee J, Lee D, Othmer HG. Synergistic Effects of Bortezomib-OV Therapy and Anti-Invasive Strategies in Glioblastoma: A Mathematical Model. Cancers (Basel) 2019;11:E215. [PMID: 30781871 DOI: 10.3390/cancers11020215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Thorburn A, Thamm DH, Gustafson DL. Autophagy and cancer therapy. Mol Pharmacol. 2014;85:830-838. [PMID: 24574520 DOI: 10.1124/mol.114.091850] [Cited by in Crossref: 174] [Cited by in F6Publishing: 176] [Article Influence: 24.9] [Reference Citation Analysis]
16 Varisli L, Cen O, Vlahopoulos S. Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways. Immunology 2020;159:257-78. [PMID: 31782148 DOI: 10.1111/imm.13160] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
17 Gañán-Gómez I, Estañ-Omaña MC, Sancho P, Aller P, Boyano-Adánez MC. Mechanisms of resistance to apoptosis in the human acute promyelocytic leukemia cell line NB4. Ann Hematol 2015;94:379-92. [PMID: 25322811 DOI: 10.1007/s00277-014-2237-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
18 Gracia-sancho J, Guixé-muntet S, Hide D, Bosch J. Modulation of autophagy for the treatment of liver diseases. Expert Opinion on Investigational Drugs 2014;23:965-77. [DOI: 10.1517/13543784.2014.912274] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
19 Vaeteewoottacharn K, Kariya R, Matsuda K, Taura M, Wongkham C, Wongkham S, Okada S. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma. J Cancer Res Clin Oncol. 2013;139:1551-1562. [PMID: 23877657 DOI: 10.1007/s00432-013-1473-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
20 Xu W, Guo W, Lu P, Ma D, Liu L, Yu F. Identification of an autophagy-related gene signature predicting overall survival for hepatocellular carcinoma. Biosci Rep 2021;41:BSR20203231. [PMID: 33351066 DOI: 10.1042/BSR20203231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Kim Y, Yoo JY, Lee TJ, Liu J, Yu J, Caligiuri MA, Kaur B, Friedman A. Complex role of NK cells in regulation of oncolytic virus-bortezomib therapy. Proc Natl Acad Sci U S A 2018;115:4927-32. [PMID: 29686060 DOI: 10.1073/pnas.1715295115] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
22 Wu N, Li J, Luo H, Wang D, Bai X. Hydroxysafflor yellow A promotes apoptosis via blocking autophagic flux in liver cancer. Biomed Pharmacother 2021;136:111227. [PMID: 33485070 DOI: 10.1016/j.biopha.2021.111227] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
23 Seo HY, Jang BK, Jung YA, Lee EJ, Kim HS, Jeon JH, Kim JG, Lee IK, Kim MK, Park KG. Phospholipase D1 decreases type I collagen levels in hepatic stellate cells via induction of autophagy. Biochem Biophys Res Commun. 2014;449:38-43. [PMID: 24802400 DOI: 10.1016/j.bbrc.2014.04.149] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
24 Farra R, Dapas B, Baiz D, Tonon F, Chiaretti S, Del Sal G, Rustighi A, Elvassore N, Pozzato G, Grassi M. Impairment of the Pin1/E2F1 axis in the anti-proliferative effect of bortezomib in hepatocellular carcinoma cells. Biochimie. 2015;112:85-95. [PMID: 25742740 DOI: 10.1016/j.biochi.2015.02.015] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
25 Ciombor KK, Feng Y, Benson AB, Su Y, Horton L, Short SP, Kauh JS, Staley C, Mulcahy M, Powell M. Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group. Invest New Drugs. 2014;32:1017-1027. [PMID: 24890858 DOI: 10.1007/s10637-014-0111-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.6] [Reference Citation Analysis]
26 Towers CG, Thorburn A. Circumventing autophagy inhibition. Cell Cycle 2019;18:3421-31. [PMID: 31736401 DOI: 10.1080/15384101.2019.1692483] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Hirosawa T, Ishida M, Ishii K, Kanehara K, Kudo K, Ohnuma S, Kamei T, Motoi F, Naitoh T, Selaru FM, Unno M. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer. PLoS One 2018;13:e0206643. [PMID: 30395583 DOI: 10.1371/journal.pone.0206643] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
28 Ding Y, Chen X, Wang B, Yu B, Ge J. Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells. Eur J Pharmacol 2018;825:10-8. [PMID: 29454609 DOI: 10.1016/j.ejphar.2018.02.020] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
29 Dash S, Chava S, Chandra PK, Aydin Y, Balart LA, Wu T. Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response. Hepat Med 2016;8:9-20. [PMID: 26955295 DOI: 10.2147/HMER.S63700] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
30 Verbaanderd C, Maes H, Schaaf MB, Sukhatme VP, Pantziarka P, Sukhatme V, Agostinis P, Bouche G. Repurposing Drugs in Oncology (ReDO)-chloroquine and hydroxychloroquine as anti-cancer agents. Ecancermedicalscience. 2017;11:781. [PMID: 29225688 DOI: 10.3332/ecancer.2017.781] [Cited by in Crossref: 100] [Cited by in F6Publishing: 101] [Article Influence: 25.0] [Reference Citation Analysis]
31 Hu T, Li P, Luo Z, Chen X, Zhang J, Wang C, Chen P, Dong Z. Chloroquine inhibits hepatocellular carcinoma cell growth in vitro and in vivo. Oncol Rep. 2016;35:43-49. [PMID: 26530158 DOI: 10.3892/or.2015.4380] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
32 Kato M, Ospelt C, Gay RE, Gay S, Klein K. Dual Role of Autophagy in Stress-Induced Cell Death in Rheumatoid Arthritis Synovial Fibroblasts: Autophagy in RA. Arthritis & Rheumatology 2014;66:40-8. [DOI: 10.1002/art.38190] [Cited by in Crossref: 78] [Cited by in F6Publishing: 73] [Article Influence: 9.8] [Reference Citation Analysis]
33 Wang Z, Han W, Sui X, Fang Y, Pan H. Autophagy: A novel therapeutic target for hepatocarcinoma (Review). Oncol Lett. 2014;7:1345-1351. [PMID: 24765136 DOI: 10.3892/ol.2014.1916] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
34 Huang IT, Dhungel B, Shrestha R, Bridle KR, Crawford DHG, Jayachandran A, Steel JC. Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma. Expert Opin Investig Drugs 2019;28:7-18. [PMID: 30474444 DOI: 10.1080/13543784.2019.1551359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
35 Kao C, Chao A, Tsai CL, Chuang WC, Huang WP, Chen GC, Lin CY, Wang TH, Wang HS, Lai CH. Bortezomib enhances cancer cell death by blocking the autophagic flux through stimulating ERK phosphorylation. Cell Death Dis 2014;5:e1510. [PMID: 25375375 DOI: 10.1038/cddis.2014.468] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 9.1] [Reference Citation Analysis]
36 Dang L, Wen F, Yang Y, Liu D, Wu K, Qi Y, Li X, Zhao J, Zhu D, Zhang C, Zhao S. Proteasome inhibitor MG132 inhibits the proliferation and promotes the cisplatin-induced apoptosis of human esophageal squamous cell carcinoma cells. Int J Mol Med 2014;33:1083-8. [PMID: 24584782 DOI: 10.3892/ijmm.2014.1678] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
37 Chen YJ, Wu H, Shen XZ. The ubiquitin-proteasome system and its potential application in hepatocellular carcinoma therapy. Cancer Lett 2016;379:245-52. [PMID: 26193663 DOI: 10.1016/j.canlet.2015.06.023] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
38 Pandey A, Yadav P, Shukla S. Unfolding the role of autophagy in the cancer metabolism. Biochem Biophys Rep 2021;28:101158. [PMID: 34754952 DOI: 10.1016/j.bbrep.2021.101158] [Reference Citation Analysis]
39 Goldsmith J, Levine B, Debnath J. Autophagy and cancer metabolism. Methods Enzymol. 2014;542:25-57. [PMID: 24862259 DOI: 10.1016/b978-0-12-416618-9.00002-9] [Cited by in Crossref: 68] [Cited by in F6Publishing: 49] [Article Influence: 11.3] [Reference Citation Analysis]
40 Granato M, Santarelli R, Lotti LV, Di Renzo L, Gonnella R, Garufi A, Trivedi P, Frati L, D'Orazi G, Faggioni A, Cirone M. JNK and macroautophagy activation by bortezomib has a pro-survival effect in primary effusion lymphoma cells. PLoS One 2013;8:e75965. [PMID: 24086672 DOI: 10.1371/journal.pone.0075965] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
41 Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao Q, Shen ZZ, Huang XY, Chen H, Yu DD, Liu LX, Zhang PF, Zhang C, Hu MY, Yang LX, Shi YH, Wang XY, Ding ZB, Qiu SJ, Sun HC, Zhou J, Shi YG, Fan J. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatology 2015;61:1603-14. [PMID: 25557975 DOI: 10.1002/hep.27682] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 10.2] [Reference Citation Analysis]
42 Johnson DE. The ubiquitin-proteasome system: opportunities for therapeutic intervention in solid tumors. Endocr Relat Cancer. 2015;22:T1-17. [PMID: 24659480 DOI: 10.1530/erc-14-0005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 35] [Article Influence: 8.7] [Reference Citation Analysis]
43 Zhang Y, Chen P, Hong H, Wang L, Zhou Y, Lang Y. JNK pathway mediates curcumin-induced apoptosis and autophagy in osteosarcoma MG63 cells. Exp Ther Med 2017;14:593-9. [PMID: 28672972 DOI: 10.3892/etm.2017.4529] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
44 Di Lernia G, Leone P, Solimando AG, Buonavoglia A, Saltarella I, Ria R, Ditonno P, Silvestris N, Crudele L, Vacca A, Racanelli V. Bortezomib Treatment Modulates Autophagy in Multiple Myeloma. J Clin Med 2020;9:E552. [PMID: 32085480 DOI: 10.3390/jcm9020552] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
45 Xie X, White EP, Mehnert JM. Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma. PLoS One. 2013;8:e55096. [PMID: 23383069 DOI: 10.1371/journal.pone.0055096] [Cited by in Crossref: 89] [Cited by in F6Publishing: 88] [Article Influence: 11.1] [Reference Citation Analysis]
46 Rao G, Nkepang G, Xu J, Yari H, Houson H, Teng C, Awasthi V. Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S Proteasome. Front Chem 2018;6:392. [PMID: 30280096 DOI: 10.3389/fchem.2018.00392] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
47 Toscani D, Palumbo C, Dalla Palma B, Ferretti M, Bolzoni M, Marchica V, Sena P, Martella E, Mancini C, Ferri V, Costa F, Accardi F, Craviotto L, Aversa F, Giuliani N. The Proteasome Inhibitor Bortezomib Maintains Osteocyte Viability in Multiple Myeloma Patients by Reducing Both Apoptosis and Autophagy: A New Function for Proteasome Inhibitors: BORTEZOMIB MAINTAINS OSTEOCYTE VIABILITY IN MM PATIENTS. J Bone Miner Res 2016;31:815-27. [DOI: 10.1002/jbmr.2741] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 6.3] [Reference Citation Analysis]